These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17179744)

  • 1. RNA interference: from biology to drugs and therapeutics.
    Appasani K
    RNA Biol; 2004 Jul; 1(2):118-21. PubMed ID: 17179744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi extravaganza: from biochemistry to drugs and therapeutics.
    Appasani K
    Pharmacogenomics; 2007 Aug; 8(8):889-93. PubMed ID: 17716223
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype.
    Hebert CG; Valdes JJ; Bentley WE
    Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi: From Biology to Therapeutics--Second Annual Conference. 30 January-1 February 2005, Berlin, Germany.
    Samarsky D
    IDrugs; 2005 Mar; 8(3):219-21. PubMed ID: 15772893
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference in biology and medicine.
    Milhavet O; Gary DS; Mattson MP
    Pharmacol Rev; 2003 Dec; 55(4):629-48. PubMed ID: 14657420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi: for functional analysis and target validation.
    Rondinone CM
    Expert Opin Ther Targets; 2006 Apr; 10(2):337-40. PubMed ID: 16548782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic Research Institute--first international siRNA conference. Prospect for new therapeutics and commercial opportunities for pharma and biotech. 24-25 March 2003, LaJolla, CA, USA.
    Xu J
    IDrugs; 2003 May; 6(5):449-50. PubMed ID: 12841209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three researchers developing therapies based on RNA interference talk about their experiences leaving academia for biotech companies.
    Bonetta L
    Biotechniques; 2007 Apr; 42(4 Suppl):S10-11, S16. PubMed ID: 18798733
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational optimization of proteins as drugs: a new era of 'medicinal biology'.
    Szymkowski DE
    Drug Discov Today; 2004 May; 9(9):381-3. PubMed ID: 15081952
    [No Abstract]   [Full Text] [Related]  

  • 11. Promise and challenge of RNA interference-based therapy for cancer.
    Petrocca F; Lieberman J
    J Clin Oncol; 2011 Feb; 29(6):747-54. PubMed ID: 21079135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Screening Asia Conference 2010: an update.
    Chaguturu R
    Future Med Chem; 2011 Apr; 3(5):513-7. PubMed ID: 21526893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential.
    Calderón AJ; Lavergne JA
    P R Health Sci J; 2005 Mar; 24(1):27-33. PubMed ID: 15895874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conference report: Bioanalysis highlights from the 2012 American Association of Pharmaceutical Scientists National Biotechnology Conference.
    Crisino RM; Geist B; Li J
    Bioanalysis; 2012 Sep; 4(17):2103-7. PubMed ID: 23013391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.
    Piascik P
    Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conference report: update on Probe Discovery World Congress 2009.
    Chaguturu R
    Future Med Chem; 2010 Mar; 2(3):311-5. PubMed ID: 21426168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
    Bobbin ML; Rossi JJ
    Annu Rev Pharmacol Toxicol; 2016; 56():103-22. PubMed ID: 26738473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating RNA interference into therapies for human disease.
    Mahanthappa N
    Pharmacogenomics; 2005 Dec; 6(8):879-83. PubMed ID: 16296951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of biotechnology in pharmaceutical drug design].
    Gaisser S; Nusser M
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):732-7. PubMed ID: 21147436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.